The combination of ramucirumab with trifluridine/tipiracil failed to show improvements in overall survival vs TAS-102 alone ...

Treatment with Cyramza plus Lonsurf did not improve overall survival compared with Lonsurf alone in heavily pretreated ...

David A. Eichenbaum, MD, presented key data from two clinical trials focusing on therapies for age-related macular ...

In an international multicenter randomized phase 3 clinical trial led by Dana-Farber Cancer Institute, researchers tested the addition of the immune checkpoint inhibitor (ICI) nivolumab to treatment ...

Tivozanib Plus Nivolumab vs Tivozanib Monotherapy in Patients with Renal Cell Carcinoma Following an Immune Checkpoint ...

Adding bevacizumab to the combination therapy of carboplatin and paclitaxel significantly improved progression-free survival ...

2024年9月4日，美国旧金山和中国苏州——信达生物制药集团（香港联交所股票代码：01801），一家致力于研发、生产和销售肿瘤、自身免疫、代谢、眼科等重大疾病领域创新药物的生物制药公司，宣布其PD-1/IL-2 α-bias ...

In addition, while G-1 treatment restored the levels of sFLT-1 (soluble fms-like tyrosine kinase-1) in RUPP rats, hydralazine did not normalize this antiangiogenic factor. The therapeutic intervention ...

DECLAN RICE has donated £5,000 to a GoFundMe campaign set up for a West Ham Under-15s goalkeeper who is fighting brain cancer. Rice, a former Hammers youth star himself, made 245 appearances ...

Desperate to save her son's life, Natalie has turned her attention to the medulloblastoma European multitarget metronomic antiangiogenic trial offered in France. Oscar has been accepted onto one ...